↓ Skip to main content

Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behçet’s disease: a large-scale, long-term postmarketing surveillance in Japan

Overview of attention for article published in Arthritis Research & Therapy, January 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
63 Mendeley
Title
Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behçet’s disease: a large-scale, long-term postmarketing surveillance in Japan
Published in
Arthritis Research & Therapy, January 2019
DOI 10.1186/s13075-018-1793-7
Pubmed ID
Authors

Shigeaki Ohno, Itsuro Umebayashi, Miyuki Matsukawa, Takashi Goto, Toshiro Yano

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 63 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 13%
Student > Bachelor 6 10%
Researcher 4 6%
Professor > Associate Professor 4 6%
Student > Doctoral Student 3 5%
Other 14 22%
Unknown 24 38%
Readers by discipline Count As %
Medicine and Dentistry 17 27%
Pharmacology, Toxicology and Pharmaceutical Science 6 10%
Nursing and Health Professions 4 6%
Immunology and Microbiology 3 5%
Agricultural and Biological Sciences 2 3%
Other 6 10%
Unknown 25 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 January 2019.
All research outputs
#3,711,927
of 25,385,509 outputs
Outputs from Arthritis Research & Therapy
#866
of 3,381 outputs
Outputs of similar age
#81,764
of 443,642 outputs
Outputs of similar age from Arthritis Research & Therapy
#47
of 73 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 443,642 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.